Home | Publications | Biotechnology place holder
place holder place holder

Biotechnology

Stem Cell Research


Publication Date   January 2008
Publisher   RI Technologies
Product Type   Report
Pages   326
ISBN Number   not applicable
Product Code   RIT008
Ask a question about this product?

Price £2,110.00

approximately: $3,644 | €2,679

Summary


This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. The study provides a market insight into the ever progressing and debatable market of Stem Cell Research segmented by type, technology and therapeutic area. Stem Cells by Type are further classified into Adult Stem Cells, Embryonic Stem Cells, and Cord Blood Stem Cells. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking, and Other. The Therapeutic applications of Stem Cell Research are analyzed by area into Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes, Dermatology and Other. Projections and estimates are graphically illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 61 major companies are discussed in the report. The report serves as a guide to global Stem Cell industry covering 521companies that are engaged in stem cell R&D, storage, banking, discovery, testing and supply of products and services. Major Contract Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Exclusive graphical representations are provided for 152 exhibits.

Content


  • I. Scope And Methodology
  • II. Report Synopsis
    • 1. Foreword
      • Segmentation of Stem Cells
      • Exhibit 1: Segmentation of Global Stem Cells Market by Stem Cell Type (Adult Stem Cells, Embryonic Stem Cells and Cord Blood Stem Cells), Technology (SC Transplantation, Cell Based Genomics, Xenotransplantation, Cord Blood Banking and Other) and Therapeutic Area (Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other)
    • 2. Global Market Analysis
      • Exhibit 2: Stem Cells (2005-2011) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Analysis by Stem Cell Type
      • Adult Stem Cells
      • Market Overview
      • Exhibit 3: Adult Stem Cells (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 4: Adult Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Cord Blood Stem Cells
      • Market Overview
      • Exhibit 5: Cord Blood Stem Cells (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 6: Cord Blood Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Embryonic Stem Cells
      • Market Overview
      • Exhibit 7: Embryonic Stem Cells (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 8: Embryonic Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Analysis by Technology
      • Stem Cell Transplantation
      • Market Overview
      • Exhibit 9: Stem Cell Transplantation (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 10: Stem Cell Transplantation (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Cell Based Genomics
      • Market Overview
      • Exhibit 11: Cord Blood (CB) Genomics (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 12: Cord Blood (CB) Genomics (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Xenotransplantation
      • Market Overview
      • Exhibit 13: Xenotransplantation (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 14: Xenotransplantation (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Cord Blood Banking
      • Market Overview
      • Exhibit 15: Cord Blood Banking (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 16: Cord Blood Banking (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Other Stem Cell Technologies
      • Exhibit 17: Other Stem Cell Technologies (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 18: Other Stem Cell Technologies (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Analysis by Therapeutic Area
      • Neurology
      • Market Overview
      • Exhibit 19: Stem Cells in Neurology (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 20: Stem Cells in Neurology (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Bone and Cartilage
      • Market Overview
      • Exhibit 21: Stem Cells in Bone and Cartilage Therapy (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 22: Stem Cells in Bone and Cartilage Therapy (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Cancer
      • Market Overview
      • Exhibit 23: Stem Cells in Cancer Therapy (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 24: Stem Cells in Cancer Therapy (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Hematology
      • Market Overview
      • Exhibit 25: Stem Cells in Hematology (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 26: Stem Cells in Hematology (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Cardiology
      • Market Overview
      • Exhibit 27: Stem Cells in Cardiology (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 28: Stem Cells in Cardiology (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Diabetes
      • Market Overview
      • Exhibit 29: Stem Cells in Diabetes Treatment (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 30: Stem Cells in Diabetes Treatment (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Other
      • Exhibit 31: Stem Cells in Other Therapeutics (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 32: Stem Cells in Neurology (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
      • Exhibit 33: List of Major Global Companies
    • 3. Regional Market Analysis
      • North America
      • Exhibit 34: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Major Companies in North America
      • Europe
      • Exhibit 35: Stem Cells (2005-2011) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Major Companies in Europe
      • Asia-Pacific
      • Exhibit 36: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Major Companies in Asia-Pacific
      • Rest of World
      • Exhibit 37: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
      • Major Companies in Rest of World
  • III. Product/Technology Research
    • 1. Introduction
      • Stem Cells
      • Stem Cells Growth Trends - Global Markets
      • Exhibit 38: Global Market for Stem Cells: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Cell Differentiation
      • Totipotent Stem Cells
      • Pluripotent Stem Cells
      • Multipotent Stem Cells
      • Unipotent Stem Cells
      • Importance of Stem Cells
      • Properties of Stem Cells
      • Stem Cell Research
      • Backdrop
      • Major Milestones in Stem Cell Research
      • Exhibit 39: The Evolution of Stem Cell Research
      • Categorization of Stem Cells
      • Global Market Growth Trends - Stem Cell Categories
      • Exhibit 40: Global Market for Stem Cells: Major Stem Cell Categories (CB Stem Cell, Embryonic Stem Cell and Adult Stem Cell) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Embryonic Stem Cells
      • Derivation of Embryonic Stem Cells
      • Differentiation of hESCs
      • Directed Differentiation
      • Directed Differentiation of hESCs in Chemically Defined Medium conditions
      • Adult Stem Cells
      • Various Tests for Detection of Adult Stem Cells
      • Differentiation of Adult Stem Cells
      • Adult Stem Cell Plasticity and Transdifferntiation
      • Applications of Adult Stem Cells
      • Major Disease Areas of Adult Stem Cells
      • Cord Blood Stem Cells
      • Derivation of Stem Cells: Cord Blood Vs Bone Marrow
      • Stem Cells and Technologiies
      • Growth Trends - Global Stem Cell Technologies
      • Exhibit 41: Global Market for Stem Cells: Major Stem Cell Technologies (Cord Blood Banking, Xenotransplantaiton, SC Transplantation, CB Genomics and Other) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Stem Cell Transplantation
      • Need for Stem Cell Transplantation
      • The Process of Stem Cell Transplantation
      • Growth Trends - Global Market for Stem Cell Transplantation
      • Exhibit 42: Global Market for Stem Cell Transplantation: Geographic Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Cell Based Gene Therapy
      • Growth Trends - Global Market for Cell Based Gene Therapy
      • Exhibit 43: Global Market for Cell Based Gene Therapy: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Xenotransplantation
      • Malfunctioning of Stem Cells Used for Xenotransplantation
      • Growth Trends - Global Market for Xenotransplantation
      • Exhibit 44: Global Market for Xenotransplantation: Geographic Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Cord Blood Banking
      • Exhibit 45: Global Private Cord Blood Banks by Geographic Region (2006) (Graphical Representation included)
      • Applications of Cord Blood
      • Growth Trends - Global Market for Cord Blood Banking
      • Exhibit 46: Global Market for Cord Blood Banking: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Other Technologies Related to Stem Cells
      • Stem Cell Research and Cloning
      • The Process of Cloning
      • Stem cell cultivation
      • How Stem Cell Research Differ from Cloning?
      • Stem cell Therapy and Mammalian Cloning
      • The Challenges
      • Cloning Technologies
      • Therapeutic Cloning
      • Reproductive Cloning
      • Somatic Cell Nuclear Transfer
      • Limitations of SCNT
      • Concerns with Stem Cell Research
      • Ethical Issues in Stem Cell Research
    • 2. Embryonic Stem Cell Research
      • Growth Trends - Global Market for Embryonic Stem Cells
      • Exhibit 47: Global Market for Embryonic Stem Cells: Geographic Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Therapeutic Applications and Research Prospects
      • Multipotent Adult Progenitor Cells
      • Therapeutic Applications - The ESC Approach
      • Human ESCs Replication for Tissue Repair and Transplantation
      • Embryonic Stem Cells Application for Heart Disease
      • Human and Mouse Embryonic Stem Cell - The Proteomic Approach
      • Undifferentiated Human Embryonic Stem Cells for Formation of Blood Cells
      • Human Embryonic Stem Cell (hESC) Lines
      • Embryo Selection
      • The Process of hESCs Derivation
      • Blastocyst Embryo Tran93 Genetic Handling of hESCs
      • hESC Markers
      • Single-Cell Embryo Biopsy
      • Stem Cell Derivation through Embryo Biopsy
    • 3. Adult Stem Cell Research
      • Growth Trends - Global Market for Adult Stem Cells
      • Exhibit 48: Global Market for Adult Stem Cells: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Types of HSCs
      • The Short-Term Precursor or Progenitor Cells
      • The Long-Term HSCs
      • Characteristics of HSCs
      • Sources of Hematopoietic Stem Cells
      • Bone Marrow
      • Peripheral Circulating Blood
      • Advantages of HSCs
      • Challenges in the Research of HSCs
      • Clinical Application of Hematopoietic Stem Cells
      • Leukemia and Lymphoma
      • Hereditary Blood Disorders
      • Hematopoietic Stem Cell Rescue in Treatment of Cancer
      • Treatment of Cancerous Tumors
      • Other Applications of HSCs
      • Plasticity of Hematopoietic Stem Cells
      • Challenges in Developing HSC Treatments
    • 4. Cord Blood Stem Cells
      • Growth Trends - Global Market for Cord Blood Stem Cells
      • Exhibit 49: Global Market for Cord Blood Stem Cells: Geographic Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Collection Process of Cord Blood
      • Cryo-Preservation of Cord Blood Stem Cells
      • Artificial Cryo-Preservation
      • Advantages of Cord Blood
      • Other Side of the Coin
    • 5. Stem Cells in Therapeutics
      • Growth Trends - Global Stem Cell Therapeutic Areas
      • Exhibit 50: Global Market for Stem Cells: Major Therapeutic Areas (Neurology, Bone and Cartilage, Diabetes, Hematology, Cardiology, Cancer and Other) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Cancer
      • BMT and PBSCT: Cancer Treatment
      • BMT and PBSCT - Cancer Types
      • Extraction of Stem Cells
      • Extraction from Bone Marrow
      • Risk Factors for the Donor
      • Extraction from Peripheral Blood
      • Risk Factors for the Donor
      • Extraction from Umbilical Cord
      • Cancer Stem Cell Transplant Process
      • Mini-Transplant
      • Tandem Transplant
      • Post Transplant Functioning of Stem Cells
      • Expenses for BMT or PBSCT
      • Cancer Immunotherapy
      • Scientific Resources of Cancer Immunotherapy
      • NK-92 Cell Based Cancer Therapy
      • Genetically Modified NK-92 Cells for Cancer Therapy
      • Stem Cell Vaccines for Cancer Therapy - Developed by Gene Modification
      • Dendritic Cell Vaccines
      • Fundamentals of Dendritic Cell Vaccines
      • The B-Cell Vaccine variety
      • Hybrid cell vaccination
      • General Side Effects with Stem Cell Transplantation
      • Consequences and Medication
      • Complications with PBSCT in Breast Cancer Patients
      • Growth Trends - Global Market for Stem Cells in Cancer Treatment
      • Exhibit 51: Global Market for Stem Cells in Cancer Treatment: Geographic Regions (Asia-Pacific, North America, Europe and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Cardiovascular Disorders
      • Cardiac Stem Cells
      • Myocyte Formation from Cardiac Stem Cells
      • Stem Cell Transplants for Congestive Heart Failure
      • Autologous Adult Stem Cell Transplantation
      • Myocardial Regeneration
      • Treatment for Ischemic Heart Failure with Cellular Cardiomyoplasty
      • The Relation between Left Ventricular Function and Release of Cardioactive Cytokines
      • Cell-Based Myocardial Repair
      • Autologous Skeletal Myoblasts
      • Cardiocytes and Stem Cells
      • Stem Cells Therapeutic Application for Cardiovascular Syndrome
      • Severe Coronary Artery Disease - Stem Cell Approach
      • Stem Cells Therapy for Hepatic Disorders
      • Growth Trends - Global Market for Stem Cells in Cardiovascular Disorders Treatment
      • Exhibit 52: Global Market for Stem Cells in Cardiovascular Disorders Treatment: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Neurological Disorders - Stem Cell Therapy
      • Properties of Neural Stem Cells
      • Transformation of Neural Stem Cells into Other Cell Types
      • The Process of Transformation
      • Molecular Mechanisms
      • Stem Cells in Other Neoplasms
      • Cell Therapy for Neurodegenerative Disorders
      • Is Alzheimer€s can be cured with Stem Cells?
      • Alternative Methods for Alzheimer€s Treatment
      • Stem Cell Therapy for Amyotrophic Lateral Sclerosis
      • Stroke Therapy using Human Adult Neural Stem Cells
      • Acute Ischemic Stroke
      • Cerebral Palsy Treatment - The Stem Cell Approach
      • Role of Chemokines 138 Techniques and Risks for Stem Cell Therapy
      • Stem Cell Therapy for Traumatic Brain Injury
      • Ischemic Brain Injury - One More Guaranteed Path for Stem Cell Therapy
      • Stem Cell Transplantation - A Novel Approach to Epilepsy Treatment
      • Growth Trends - Global Market for Stem Cells in Neurological Disorders Treatment
      • Exhibit 53: Global Market for Stem Cells in Neurological Disorders Treatment: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Bone and Cartilage Regeneration
      • Application of Mesenchymal Stem Cells in Regeneration of Bone
      • Molecular and Tissue Engineering Strategies for the Use of Mesenchymal Stem Cells in Bone Regeneration
      • Application of Adult Stem Cells in Cartilage Regeneration and Tissue Engineering
      • About Mesenchymal Stem Cells
      • Clinical Applications and Future of Cell Therapy
      • Growth Trends - Global Market for Stem Cells in Bone and Cartilage Disorders Treatment
      • Exhibit 54: Global Market for Stem Cells in Bone and Cartilage Disorders Treatment: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Hematological Disorders
      • Treatment for Blood Disorders
      • Stem Cell Treatment for Blood Disorder
      • Sickle Cell Anemia
      • Gene Therapy
      • Stem Cell Transplantation
      • Cord Blood Transplantation
      • Growth Trends - Global Market for Stem Cells in Hematology
      • Exhibit 55: Global Market for Stem Cells in Hematology: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Stem Cell Therapy for Diabetes Mellitus
      • Type 1 Diabetes in Children
      • Cord Blood Stem Cells for Treatment of Type 1 Diabetes
      • Growth Trends - Global Market for Stem Cells in Diabetes Treatment
      • Exhibit 56: Global Market for Stem Cells in Diabetes Treatment: Geographic Regions (Asia-Pacific, Europe, North America and Rest of World) Ranked by Projected CAGR for 2005 through 2011 (Graphical Representation included)
      • Other Major Therapeutic Areas of Stem Cells
      • Cosmetic Applications
      • Intended Accomplishment by Stem Cells in Cosmetology
      • Renal Applications
      • The Renal Papilla is Niche for Adult Kidney Cells
      • Stem Cell Applications in Transplantable Organs
      • Orthopedic Applications
      • Spinal Cord Regeneration
      • Review of Various Cell Therapies Used In the Field Of Orthopedics
      • Endocrine Applications of Stem Cells
      • Ophthalmic Applications of Stem cells
      • Prospects of Stem-Cell Based Treatment for Eye Disorders
    • 6. Technological Advances
      • Identification of a Versatile Stem Cell in the Amniotic Fluid
      • Generation of Stem Cell Lines from the Amniotic Fluid
      • Why Caucasians are more in Number among Stem Cell Transplant Recipients?
      • The Creation of Tissue-Matched Stem Cells in Mice without the Cloning Process
      • Stem Cell Transplants -- Increased Risk for Diabetes and Hypertension
      • The Generation of Human Embryonic Stem Cell Lines from Dead Embryos
      • Self-Renewal of Embryonic Stem Cells Dependent upon the Small Molecule
    • 7. Prospective Applications
  • IV. Market Dynamics
    • 1. Market Overview
      • Global Market Analysis
      • Exhibit 57: Stem Cells (2005-2011) - Global Market Analysis (Current & Future) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million (Graphical Representation included)
      • Exhibit 58: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation included)
    • 2. Stem Cell Trends
      • The Future of Cloned F 168 Adult Stem Cells to Play Key Role in Heart Diseases
      • Use of Robotics in Stem Cell Research Automation
      • Identification of New Stem Cell with Dual Characteristics
      • Stem Cell Derivation from a Single Cell Extracted from Early Human Embryos
      • Reprogramming of Adult Stem Cells
      • Adult Stem Cells - Free of Controversy and Yield Better Results
      • Stem Cell Research Prospects in China
    • 3. Major Companies in Stem Cell Market
      • Aastrom Biosciences, Inc. (USA)
      • Advanced Cell Technology, Inc. (USA)
      • ALDAGEN, Inc. (USA)
      • Angel BioTechnology (UK)
      • Axordia (UK)
      • BioE (USA)
      • Boehringer-Ingelheim GmbH (Germany)
      • BrainStorm Cell Therapeutics, Inc. (USA)
      • Cellartis AB (Sweden)
      • Cellerix SL (Spain)
      • Cellerant Therapeutics, Inc. (USA)
      • Cells4Life Ltd. (UK)
      • Cellular Dynamics International (USA)
      • Ceregene, Inc (USA)
      • CordLife Ltd (Australia)
      • CryoGENESIS International Ltd (UK)
      • Cryo-Cell International, Inc. (USA)
      • Cryo-Save AG (Switzerl 181 Cytori Therapeutics, Inc. (USA)
      • Epistem Ltd. (UK)
      • ES Cell International (Singapore)
      • Gamida Cell Ltd. (Israel)
      • GE Healthcare (UK)
      • Genentech, Inc. (USA)
      • Geron Corporation (USA 183 Intercytex (UK)
      • Invitrogen Corp. (USA)
      • LifeCell Corp. (USA)
      • LifebankUSA (USA)
      • Lazaron Biotechnologies SA (South Africa)
      • Millipore Corp. (USA)
      • MaxCyte, Inc. (USA)
      • Mesoblast Ltd. (Australia). 187 MultiCell Technologies, Inc. (USA)
      • NeuroGeneration (USA) .. 187 Novartis AG (Switzerland 188 NovaThera Ltd (UK)
      • Novocell, Inc. (USA)
      • Novo Nordisk A/B ( 189 NsGene A/S (Denmark)
      • Osiris Therapeutics, Inc. (USA)
      • RegenTec (UK)
      • ReInnervate (UK)
      • Reliance Life Sciences (India)
      • ReNeuron Group plc (UK)
      • RhinoCyte, Inc. (USA)
      • Sanofi-Aventis (France)
      • SinoCells Bio Technologies Co., Ltd. (China)
      • Stem cell Innovation (USA)
      • Stem cell Sciences KK ( 194 Stem cell Sciences Ltd. (UK)
      • Stem Cell Therapeutics Corp. (Canada)
      • StemCell Technologies Inc. (USA)
      • StemCells Inc. (USA)
      • Stem Cell Technology Company (Iran)
      • Takara Bio, Inc. (Japan)
      • Titan Pharmaceuticals, Inc. (USA)
      • TTP Labtech Ltd. (UK)
      • Vesta Therapeutics Inc. (USA)
      • ViaCell, Inc. (USA)
      • VistaGen Therapeutics Inc. (USA)
    • 4. Major Activities in Stem Cell Market
      • Cytori Sells HYDROSORB Surgical Implant Product Line to Kensey Nash
      • Stanford Researchers Announce New Discovery in the Field of Human Stem Cells Transplantation
      • BioEden Expands Operations into Europe
      • Vitrolife Enters into Collaboration with Cellartis
      • Stem Cell Sciences Acquires Rights to Novel Discovery Technology for the Production of Human Stem Cells
      • Geron Acquires Additional Stake in TA Therapeutics Joint Venture
      • Invitrogen Introduces New Engineered Stem Cell Line
      • Roslin Researchers Derive Stem Cells from New Source
      • ReNeuron Scientists Announce Generation of Pancreatic Cell Lines
      • Discovery in ZebraFish may aid Human Blood Cell Transplants
      • Stem Cell Innovations Enters into Collaboration with High Q Foundation
      • Tissue Genesis Enters into Distribution and License Agreement with Vet-Stem
      • Stem Cells to Replace Damaged Heart Muscle
      • Advanced Cell Technology Announces the Development of hESC Line without Damaging an Embryo
      • Canadian Researchers Redefine Stem Cells
      • ThermoGenesis Enters into Agreement with University of California (UC) Stem Cell Program (SCP) ..203 Stem Cell Innovations and TNO Enter into Collaboration
      • Consensus Business Group Acquires Stake in Hadasit Bio-Holdings
      • StemLifeLine Introduces Premier Service for the Development of Personal Stem Cell Lines
      • Israeli Government Grants US$ 830,000 to Pluristem
      • Advanced Cell Technology Plans to Acquire Mytogen Inc
      • Millipore Launches MEL Cell Lines
      • ThromboGenics Enters into License Agreement with Millipore
      • Cells4Life Launches Guava PCA System
      • MIT Announces Release of Firefly 3000 Protein Assay Platform
      • GE Healthcare Releases AXP AutoXpress Platform
      • Calbatech Establishes a Subsidiary Company for Offering Stem Cell Service in the UK
      • Stemcell Signs Agreement with Aldagen for Supplying Aldecount
      • DSM Extends Partnership Agreement with Crucell
      • Merck Receives Licenses of Neural Stem Cell Technology from SCS
      • SCS Enters into MTA Pact with Henderson
      • Angel Biotechnology Enters into Alliance with CellGenea
      • MC Employs HEScGRO Medium Human Embryonic Stem Cell Study
      • Chromos Signs Contract with Genitope
      • ACT Acquires Technology Assets of Infigen
      • BCT Undertakes Research on Stem Cell Safety in Primates for Curing Parkinson€s
      • TIGENIX Joins Hands with FIDIA for Developing New Biological Implants
      • ES Cell Signs License Agreement with ITI
      • Stem Cell Innovations Signs Collaboration Agreement with ALSA
      • CyGenics Signs Partnership Agreement with ZBC
      • Mediatech Enters into Alliance with GlobalStem
      • Gamida Cell Enters into SPA Agreement with FDA
      • Vistagen Reinforces its Partnership with Sanwa
      • StemCells Carries out Phase I Studies of HuCNS-SC
      • ReNeuron and Millipore Introduce ReNcellTM Neural Stem Cell Lines
      • Aldagen Joins Hands with IMT
      • Chromos Signs Contract with Y€s Therapeutics for Developing Cell Line
      • Geron Signs Collaboration Agreement with The University of Edinburgh
      • ACT Develops New Technology for hES Cells Culture
      • Stem Cell Sciences Partners with Neurosolutions
      • Cambrex Joins Hands with Cytori to Market Stem Cell Products
      • ViaCell Enters into Alliance with Centocor
      • Pierre Fabre Employs SURE Technology for Developing Mammalian Cell Lines
      • PrimeGen Emphasizes on PrimeCell Development
      • CellResearch Develops New Range of Cord Lining Stem Cells
      • Geron Joins Hands with University of Oxford
      • Cryo-Cell Commences Web-Interface for Placental Stem cells
      • Aldagen Receives US Patent Rights for Key Stem Cell
      • Geron Signs Pact with MaxCyte
      • Vitro Joins Hands with PhosphoSolutions for Stem Cell Proteomics Study
      • Xcyte Merges with Cyclacel to Form Biopharmaceutical MNC
      • StemCo Adopts New Corporate Identity (Aldagen)
      • Cytori Therapeutics Signs Collaboration Agreement with Olympus
      • Cryo-Cell Signs Global Marketing Agreement with Plureon
      • Artificial Life Associates with BeFutur
      • LCT Enters into Joint Venture Agreement with MultiCell
      • SAFC Biosciences Signs Partnership Agreement with Chromos
      • Axordia Collaborates with Chemicon for Developing Human Embryonic Stem Cell Antibody Markers
      • A.C.T. Renames as Advanced Cell Technology
      • U.S. BioDefense Enteres into Collaboration with University of Texas
      • ViaCell Enters into Alliance with Genzyme on Diabetes Program
      • Geron Enters into Alliance with Cambrex to Develop and Market Human Cell Lines
    • 5. Regional Market Analysis
      • A. North America
        • Market Analysis
        • Exhibit 59: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
        • Analysis by Geographic Region
        • Exhibit 60: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) by Geographic Region for United States, Canada and Mexico in US$ Million (Graphical Representation included)
        • Exhibit 61: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of North American Market Value by Geographic Region for United States, Canada and Mexico
        • Analysis by Stem Cell Type
        • Exhibit 62: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical Representation included)
        • Exhibit 63: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of North American Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells
        • Analysis by Technol 228 Exhibit 64: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other in US$ Million (Graphical Representation included)
        • Exhibit 65: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of North American Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other
        • Analysis by Therapeutic Area
        • Exhibit 66: Stem Cells (2005-2011) - North American Market Analysis (Current & Future) by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other in US$ Million (Graphical Representation included)
        • Exhibit 67: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of North American Market Value by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other
        • North American Stem Cell Market By Country
        • A1. United States
        • A2. Canada
        • A3. Mexico
      • B. Europe
        • Funding for Stem Cell Research in Europe
        • Cord Blood Banking in Europe
        • Market Analysis
        • Exhibit 73: Stem Cells (2005-2011) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
        • Analysis by Geographic Region
        • Exhibit 74: Stem Cells (2005-2011) - European Market Analysis (Current & Future) by Geographic Region for United Kingdom, Germany, France, Spain, Denmark and Rest of Europe in US$ Million (Graphical Representation included)
        • Exhibit 75: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, France, Spain, Denmark and Rest of Europe (Graphical Representation included)
        • Market Analysis for Select Rest of Europe Countries
        • Exhibit 76: Stem Cells (2005-2011) - Rest of Europe Market Analysis (Current & Future) by Country for Russia, Sweden, Switzerland, Poland, Austria and Greece in US$ Million (Graphical Representation included)
        • Exhibit 77: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of Europe Market Value by Geographic Region for Russia, Sweden, Switzerland, Poland, Austria and Greece
        • Analysis by Stem Cell Type
        • Exhibit 78: Stem Cells (2005-2011) - European Market Analysis (Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical Representation included)
        • Exhibit 79: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of European Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells
        • Analysis by Technology
        • Exhibit 80: Stem Cells (2005-2011) - European Market Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other in US$ Million (Graphical Representation included)
        • Exhibit 81: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of European Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other
        • Analysis by Therapeutic Area
        • Exhibit 82: Stem Cells (2005-2011) - European Market Analysis (Current & Future) by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other in US$ Million (Graphical Representation included)
        • Exhibit 83: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of European Market Value by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other
        • European Stem Cell Market By Country
        • B1. The United Kingdom
        • B2. Germany
        • B3. France
        • B4. Spain
        • B5. Denmark
        • B6. Russia
        • B7. Sweden
        • B8. Switzerland
        • B9. Poland
        • B10. Austria
        • B11. Greece
      • C. Asia-Pacific
        • Market Analysis
        • Exhibit 103: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
        • Analysis by Geographic Region
        • Exhibit 104: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for India, China, Japan, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)
        • Exhibit 105: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for India, China, Japan, Australia and Rest of Asia-Pacific
        • Market Analysis for Select Rest of Asia-Pacific Countries
        • Exhibit 106: Stem Cells (2005-2011) - Rest of Rest of Asia-Pacific Market Analysis (Current & Future) by Country for South Korea, Hong Kong, Singapore, New Zealand and Taiwan in US$ Million (Graphical Representation included)
        • Exhibit 107: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Geographic Region for South Korea, Hong Kong, Singapore, New Zealand and Taiwan
        • Analysis by Stem Cell Type
        • Exhibit 108: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical Representation included)
        • Exhibit 109: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Asia-Pacific Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells
        • Analysis by Technology
        • Exhibit 110: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other in US$ Million (Graphical Representation included)
        • Exhibit 111: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Asia-Pacific Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other
        • Analysis by Therapeutic Area
        • Exhibit 112: Stem Cells (2005-2011) - Asia-Pacific Market Analysis (Current & Future) by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other in US$ Million (Graphical Representation included)
        • Exhibit 113: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Asia-Pacific Market Value by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other
        • Asia-Pacific Stem Cell Market by Country
        • C1. India
        • C2. China
        • C3. Japan
        • C4. Australia
        • C5. South Korea
        • C6. Hong Kong
        • C7. Singapore
        • C8. New Zealand
        • C9. Taiwan
      • D. Rest of World
        • Market Analysis
        • Exhibit 128: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)
        • Analysis by Geographic Region
        • Exhibit 129: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) by Geographic Region for Latin America, Middle East and Africa in US$ Million (Graphical Representation included)
        • Exhibit 130: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of World Market Value by Geographic Region for Latin America, Middle East and Africa
        • Market Analysis for Select Latin American Countries
        • Exhibit 131: Stem Cells (2005-2011) - Latin American Market Analysis (Current & Future) by Geographic for Brazil, Columbia, Argentina and Rest of Latin America in US$ Million (Graphical Representation included)
        • Exhibit 132: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Latin American Market Value by Geographic Region for Brazil, Columbia, Argentina and Rest of Latin America
        • Market Analysis for Israel and Rest of Middle East
        • Exhibit 133: Stem Cells (2005-2011) - Middle East Market Analysis (Current & Future) by Geographic for Israel and Rest of Middle East in US$ Million (Graphical Representation included)
        • Exhibit 134: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Middle East Market Value by Geographic Region for Israel and Rest of Middle East
        • Analysis by Stem Cell Type
        • Exhibit 135: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells in US$ Million (Graphical Representation included)
        • Exhibit 136: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of World Market Value by Category for Adult Stem Cells, Cord Blood Stem Cells and Embryonic Stem Cells
        • Analysis by Technology
        • Exhibit 137: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other in US$ Million (Graphical Representation included)
        • Exhibit 138: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of World Market Value by Stem Cell Technology for Stem Cell (SC) Transplantation, Cord Blood (CB) Genomics, Xenotransplanstation, Cord Blood Banking and Other
        • Analysis by Therapeutic Area
        • Exhibit 139: Stem Cells (2005-2011) - Rest of World Market Analysis (Current & Future) by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other in US$ Million (Graphical Representation included)
        • Exhibit 140: Stem Cells (2006, 2007 and 2011) - Percentage Breakdown of Rest of World Market Value by Therapeutic Area for Neurology, Bone and Cartilage, Cancer, Hematology, Cardiology, Diabetes and Other
        • Rest of World Stem Cell Market by Country
        • D1. Brazil
        • D2. Columbia
        • D3. Argentina
        • D4. Rest of Latin America
        • D5. Israel
        • D6. Rest of Middle East
        • D7. South Africa
      • 6. Stem Cell Research - The Industry Outlook
    • V. Corporate Directory